CONFOMETRX

confometrx-logo

ConfometRx is developing a platform of structure-based drug development tools to facilitate target validation, lead identification, and lead optimization for G protein coupled receptor (GPCR) targets. This platform includes: the production of pure, functional GPCRs for high-resolution structure determination by crystallography, and the engineering of GPCRs to facilitate crystal formation; the efficient and economical expression of GPCRs for NMR-based drug discovery applications; and the generation of receptor-specific, functional antibodies for target validation, therapeutics and GPCR crystallography.

#People #Website #More

CONFOMETRX

Social Links:

Industry:
Biotechnology

Address:
Santa Clara, California, United States

Country:
United States

Website Url:
http://www.confometrx.com

Status:
Active

Contact:
408-496-6276

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema Google Apps For Business Typekit


Current Employees Featured

brian-kobilka_image

Brian Kobilka
Brian Kobilka Founder @ ConfometRx
Founder

Founder


brian-kobilka_image

Brian Kobilka

Official Site Inspections

http://www.confometrx.com

  • Host name: 198.49.23.144
  • IP address: 198.49.23.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "ConfometRx"

ConfometRx

ConfometRx is a leader in G protein coupled receptor (GPCR) structural characterization and analysis and GPCR-targeted drug discovery. 0. Skip to Content About About ConfometRx …See details»

About Us — ConfometRx

ConfometRx Research Foundation is a public non-profit foundation founded by Brian and Tong Sun Kobilka in 2009. …See details»

ConfometRx - Crunchbase Company Profile & Funding

ConfometRx is developing a platform of structure-based drug development tools to facilitate target validation, lead identification, and lead optimization for G …See details»

CONFOMETRX RESEARCH FOUNDATION

The ConfometRx Research Foundation is a public non-profit foundation founded by Brian and Tong Sun Kobilka in 2009. The goal of the foundation is to bring …See details»

Confometrx, Inc - LinkedIn

Confometrx, Inc | 226 followers on LinkedIn. Structural based drug discovery targeting GPCRs | Advancing Therapeutics Targeting Previously Intractable G-Protein Coupled Receptors (GPCRs)See details»

ConfometRx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Jan 23, 2025 Explore ConfometRx, Inc. with its drug pipeline, therapeutic area, technology platform, 2 literature, Disease Domain:Nervous System Diseases, Endocrinology and …See details»

Confometrx, Inc Overview | SignalHire Company Profile

Organization Website: confometrx.com : Confometrx, Inc industries Biotech: Headquarters Location: 3070 Kenneth St, Santa Clara, California, 95054 US 3070 Kenneth St, Santa Clar...See details»

Confometrx, Inc. Company Profile | Palo Alto, CA | Competitors ...

Find company research, competitor information, contact details & financial data for Confometrx, Inc. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»

ConfometRx Company Profile - Office Locations, Competitors

ConfometRx is a company that develops a platform for the discovery of G protein-coupled receptors (GPCR). The platform includes the production of GPCRs for structure determination …See details»

Program Pipeline - ConfometRx

About ConfometRx Foundation Approach Pipeline Publications News Work With Us ADVANCING NOVEL GPCR-TARGETED CANDIDATES. We are currently advancing multiple small molecule candidates through lead optimization and …See details»

ConfometRx - Products, Competitors, Financials, Employees, …

ConfometRx is a biotechnology company that focuses on the structural characterization and analysis of G-protein-coupled receptors (GPCRs) within the pharmaceutical industry. Use the …See details»

ConfometRx Company Profile | Management and Employees List

ConfometRx Profile and History. Confometrx Research Foundation is a public non-profit foundation founded by Brian and Tong Sun Kobilka in 2009. The specific purpose of the …See details»

Confometrx Research Foundation | Palo Alto, CA | Cause IQ

Dec 1, 2023 The Confometrx Research Foundation brings together scientists from academia, biotechnology and the pharmaceutical industry to exchange ideas and discuss challenges …See details»

ConfometRx - Overview, News & Similar companies | ZoomInfo.com

Confometrx Research Foundation is a public non-profit foundation founded by Brian and Tong Sun Kobilka in 2009. The specific purpose of the foundation is to bring together scientists from …See details»

Work With Us — ConfometRx

If interested in collaborating with us, please contact us using the form on this page or at [email protected]. Employment Opportunities. Located in the beautiful city of Mountain …See details»

CONFOMETRX, INC. - VentureRadar

CONFOMETRX, INC. VentureRadar profile. Find out more about CONFOMETRX, INC., Drug Discovery and Antibodies.See details»

Anxiety/Depression Therapy Program (ConfometRx) - Drug Targets ...

Anxiety/Depression Therapy Program (ConfometRx): a GPCR modulators Drug, Initially developed by ConfometRx, Inc., Now, its global highest R&D status is Preclinical, Mechanism: …See details»

Our Approach — ConfometRx

The ConfometRx Solution . Based on the work of our co-founder, Dr. Brian Kobilka, and others, we have developed novel methods to determine the three-dimensional structures of GPCRs in …See details»

Annual Report on Confometrx's Revenue, Growth, SWOT Analysis ...

Mar 10, 2025 Market Share of Confometrx's Largest Competitors A competitive analysis shows these companies are in the same general field as Confometrx, even though they may not …See details»

News — ConfometRx

ConfometRx unlocks novel GPCR-G protein structure within UCB research collaboration. We are pleased to announce that it has succeeded in elucidating the crystallographic structure of a …See details»